BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//bioPmed - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:bioPmed
X-ORIGINAL-URL:https://biopmed.eu
X-WR-CALDESC:Eventi per bioPmed
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Rome
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Rome:20241210T113000
DTEND;TZID=Europe/Rome:20241210T123000
DTSTAMP:20260412T060827
CREATED:20241113T155056Z
LAST-MODIFIED:20241114T133856Z
UID:12079-1733830200-1733833800@biopmed.eu
SUMMARY:SIGNAL PEPTIDE SCREENING FOR mAbs AND BITE  GENERATION USING A CHO PLATFORM
DESCRIPTION:Goals: to present the services provided by Menarini Biotech to support development of biotherapeutic molecules. The webinar will be focused on the workflow for the Signal Peptides screening studies applied to the production of two different kinds of therapeutic proteins (mAb and BITE).\nREGISTER NOW \nRecipients of the course\nCompanies\, partners\, potential clients involved in the development and manufacturing of therapeutic drugs starting from cell lines. \nWhat we learn from the course\n\nServices supplied by MENARINI Biotech as CDMO\nApproach for evaluation of Signal Peptides impact on molecules productivity\nComparison between different analytical methods for the verification of transfection efficiency\n\nSpeakers\n\nLavinia Nardinocchi\, Cell Line Development specialist Menarini Biotech\, Pomezia (Rome)\, Italy. Lavinia Nardinocchi took the Master degree in Medical\, Molecular and Cellular Biotechnology and a PhD in Molecular Medicine from the University of Rome “La Sapienza”(Italy). For 10 years she worked in the field of cancer research\, in.2015 she started working in MBH as an Upstream lab technician both in the development department and in the GMP production. Since 2022 she has been holding the role of Cell Line Development Specialist in Process Development Upstream Group. In recent years she has acquired strong skills in the development of the Upstream process and in cell line development.\nAlessandra Mariani\, Analytical Development Bioassays specialist Menarini Biotech\, Pomezia (Rome)\, Italy. Alessandra\, took the Master Degree in Medical Biotechnology at University of Perugia and the PhD in Life Science cellular physiology at GSK Vaccines- University of Siena. In 2015 she joined Menarini Biotech\, in Pomezia (Rome). Starting as laboratory technician in the Analytical Development Department\, she is currently holding the position of Analytical Development specialist as Subject Matter Expert (SME) in the Immuno-Bioassays field. Alessandra’s experience in the R&D of pharma companies was mainly focused on polyclonal and monoclonal antibodies\, in particular on the development of immunoassays\, kinetic assays and cell-based assays for antibody characterization.\n\nREGISTER NOW
URL:https://biopmed.eu/evento/signal-peptide-screening-for-mabs-and-bite-generation-using-a-cho-platform/
LOCATION:Online
CATEGORIES:Eventi bioPmed
ATTACH;FMTTYPE=image/png:https://biopmed.eu/wp-content/uploads/2024/11/WebinarbioPmed-18.png
END:VEVENT
END:VCALENDAR